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zones. Further analysis confirmed 
that α2A-ARs and HCN channels 
are found together on spine mem-
branes, often within tens of nanom-
eters of each other.
Individually, each one of these 
results is subject to possible alterna-
tive interpretations, but collectively 
they make an extremely strong case 
for the biochemical cascade pro-
posed by the authors. Furthermore, 
this cascade has immediate impli-
cations for the design of effective 
clinical therapies, because an abnor-
mal capacity for working memory 
is thought to contribute to cognitive 
deficits, such as attention deficit 
hyperactivity disorder (ADHD) (Sca-
hill et al., 2001).
It is not often that changes in behav-
ior can be traced to specific molecular 
interactions in the brain, and it is even 
more rare to see a complex cognitive 
function, such as working memory, 
dissected in this way. Indeed, the work 
by Wang et al. (2007) is a remarkable 
feat that sets a high standard for future 
research in neuroscience.
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Although many microRNAs (miRNAs) and their targets have been identified, the importance 
of miRNAs in vivo is still unclear. In this issue, Zhao et al. (2007) generate mice deficient in a 
cardiac-specific miRNA, miR-1-2, and reveal that this microRNA plays a crucial role in heart 
development and physiology.Organogenesis is a complex bio-
logical process that requires pre-
cise spatial and temporal control of 
gene expression. Recently, miRNAs 
have emerged as central post-
transcriptional repressors of gene 
expression that interact with the 3′ 
untranslated region (UTR) of spe-
cific target mRNAs (Kloosterman 
and Plasterk, 2006). In this issue of 
Cell, Zhao et al. (2007) investigate 
the role of miRNAs during cardiac 
development in mice. Using elegant 
genetics, these authors uncover 
important roles for the miRNA, miR-
1-2, during heart morphogenesis in 
the mouse embryo and for the regu-lation of cardiomyocyte proliferation 
and electrophysiology in the adult 
heart (Zhao et al., 2007).
To understand the role of miRNAs 
in the developing heart, the authors 
engineered mice that lacked the 
microRNA processing enzyme Dicer 
in heart tissue alone. These embryos 
showed cardiac failure due to a 
variety of developmental defects, 
including pericardial edema and 
underdevelopment of the ventricu-
lar myocardium. These phenotypes 
are consistent with the defects dur-
ing heart development observed in 
zebrafish embryos devoid of Dicer 
function (Giraldez et al, 2005)Cell 129To further investigate the role of 
miRNAs in cardiac development, the 
authors focused on miR-1, a highly 
abundant class of miRNAs in the 
mammalian heart. Two members 
of the miR-1 class of RNAs—miR-
1-1 and miR-1-2—are specifically 
expressed in cardiac tissue and 
skeletal muscle. miR-1-1 and miR-1-
2 are encoded separately but appear 
to target the same mRNAs. To deter-
mine the particular role of miR-1-2, 
the authors using a targeted dele-
tion strategy to eliminate the locus 
coding for miR-1-2 without affect-
ing adjacent genes. Fifty percent of 
mice lacking miR-1-2 died during , April 20, 2007 ©2007 Elsevier Inc. 247
embryonic development, dis-
playing defects in their ven-
tricular septum indicative of 
abnormal heart morphogen-
esis. Interestingly, 15% of the 
miR-1-2-deficient mice that 
did not die in utero suffered 
severe heart defects and died 
2–3 months after birth. Some 
of the remaining embryos 
survived to adulthood and 
appeared to have normal car-
diac morphology but suffered 
sudden death, suggesting 
additional functions of miR-
1-2 during postembryonic 
development.
Expression of miRNAs 
is not limited to embryonic 
stages, and most miRNAs are 
expressed continuously dur-
ing the life of a tissue or organ 
(Wienholds et al., 2005). Nev-
ertheless, current research has 
focused on their roles during 
development and has tended 248 Cell 129, April 20, 2007 ©2007figure 1. miR-1-2 function in the Mouse Heart
Absence of the cardiac-specific microRNA miR-1-2 affects 
heart morphogenesis (potential targets shown) during embry-
onic development. Mice lacking miR-1-2 that survive to adult-
hood have defects in cardiac conductivity and cardiomyocyte 
proliferation. These effects are likely through the regulation of 
the expression of the transcription factors Irx5 and Hand2 by 
miR1-2. Other putative miR-1 targets involved in cell cycle/
cancers include Hlf (hepatocyte leukemia factor) and Rbbp9 
(retinoblastoma-binding protein 9). Elsevier Inc.sary to conclusively show 
that the potential targets 
highlighted by Zhao et al. 
(2007) are indeed responsi-
ble for the observed pheno-
types. In this regard, reduc-
tion of expression of Hand2 
or Irx5 in miR-1-2-deficient 
mice should attenuate the 
observed cardiac phenotype. 
Interestingly, previous studies 
have suggested that miRNAs 
might regulate genes that are 
not essential for function of a 
particular tissue. For exam-
ple, a muscle miRNA might 
eliminate noisy expression of 
neuronal mRNAs (Lim et al., 
2005; Stark et al., 2005). In 
contrast to these observa-
tions but as predicted in the 
rheostat model (Bartel and 
Chen, 2004), the Zhao et al. 
(2007) study suggests that 
miR-1-2 indeed tunes the lev-
els of a set of targets that are to overlook miRNA function during 
adulthood (Kloosterman and Plasterk, 
2006). Zhao et al. (2007) examined the 
mice lacking miR-1-2 that survived to 
adulthood to determine the function 
of this miRNA in the adult heart. They 
observed physiological defects in the 
adult heart in the absence of miR-1-2, 
particularly an increase in cardiomyo-
cyte proliferation and electrophysio-
logical defects including reduced heart 
rate and prolonged ventricular depo-
larization. These phenotypes suggest 
that miR-1-2 has distinct functions in 
the embryonic and the adult heart, 
where it modulates the machinery 
that establishes and maintains car-
diac rhythm (Figure 1). Although these 
cardiac conductivity defects appear 
in miR-1-2-deficient heart tissue that 
appears morphologically normal, such 
defects could be reminiscent of subtle 
cardiac embryonic phenotypes. Thus, 
future experiments will need to investi-
gate the postembryonic roles of miR-1 
in the adult heart by analyzing condi-
tional knockouts that eliminate miRNA 
function after birth.
microRNAs are known to reduce 
target mRNA translation and accel-
erate mRNA decay (Lim et al., 
2005; Giraldez et al., 2006). Based on these observations, microar-
ray analyses have contributed to 
the identification of miRNA targets 
based on gain- and loss-of-function 
experiments (Lim et al, 2005; Giral-
dez et al., 2006). To investigate the 
molecular targets responsible for 
the cardiac phenotypes in miR-1-
2-deficient mice, Zhao et al. (2007) 
used microarray analysis to identify 
mRNAs upregulated in the absence 
of miR-1-2. One might predict that 
the phenotypes observed would be 
caused by misregulation of a small 
number of key effector genes. Zhao 
et al. (2007) identified a dozen puta-
tive direct targets and propose that 
misregulation of the genes encod-
ing the transcription factors Hand2 
and Irx5 is responsible for the phe-
notypes of cardiac proliferation 
(Zhao et al., 2005) and repolariza-
tion, respectively. But the whole 
picture is likely to be far more com-
plex given that miRNAs can target 
hundreds of genes (Lim et al. 2005; 
Giraldez et al., 2005). For instance, 
loss of miR-1-2 might result in dys-
regulation of multiple target genes 
that encode proteins with synergis-
tic effects during cardiac function. 
Additional experiments are neces-essential rather than extraneous for 
heart function.
Two recent studies also highlight 
the role of miRNAs in the heart. 
Yang et al. (2007) also report a func-
tion for miR-1 in heart conductiv-
ity. Interestingly, miR-1 levels were 
increased in humans with coronary 
artery disease and rats after cardiac 
infarction. Knockdown of miR-1 pre-
vented heart arrhythmia, whereas 
miR-1 overexpression caused heart 
arrhythmia in normal and infarcted 
hearts. This effect of perturbing the 
levels of miR-1 prompted the authors 
to examine potassium channel subu-
nits, which are important for cardiac 
conductance. Both the gene encod-
ing the cardiac gap junction channel 
connexin43 and the gene encoding 
the Kir2.1 subunit of a potassium 
channel were targeted by miR-1. 
Both gain- and loss-of-function of 
miR-1 affect conductivity through 
these potassium channels. Taken 
together, these results strongly 
support a central role for miR-1 in 
fine tuning the regulation of cardiac 
electrophysiology in pathological 
and normal conditions. Another link 
between miRNAs and heart disease 
was reported recently by van Rooij 
et al. (2007). Cardiac contractility 
and performance depends on the 
balanced expression of α- and β-
myosin heavy chain (MHC). During 
stress, cardiomyocytes respond by 
hypertrophic growth and reduced 
contractility due to downregulation 
of α-MHC and upregulation of β-
MHC. The authors deleted the car-
diac-specific miRNA miR-208 that 
is encoded by an intron in the α-
MHC gene. miR-208-deficient mice 
were viable and displayed no obvi-
ous cardiac phenotype within the 
first months of age. However, gene 
expression analysis revealed that 
miR-208-deficient hearts upregu-
late genes that encode fast skeletal 
muscle contractile proteins—which 
are absent in wild-type hearts—
and cardiac stress proteins. These 
genes are likely secondary miR-208 
targets because they lack canoni-
cal miR-208 complementary sites. 
Furthermore, miR-208 mutant mice 
failed to undergo stress-induced 
cardiac remodeling, hypertrophic 
growth, and β-MHC upregulation. 
Conversely, transgenic expression 
of miR-208 was sufficient to induce 
β-MHC. Given that miR-208-defi-
cient hearts resembled hyperthyroid 
hearts and that thyroid hormone 
(T3) signaling represses ß-MHC, the 
authors investigated whether miR-
208 was required for T3-depend-
ent repression of β-MHC. Repres-
sion of T3 signaling in the absence 
of miR-208 and target validation 
experiments suggest that miR-208 
regulates β-MHC by repressing the 
thyroid hormone receptor associ-
ated protein 1 (THRAP1), a cofac-
tor of the thyroid hormone receptor 
(TR) and a predicted miR-208 target 
mRNA. Thus, miR-208 is impor-
tant for cardiac growth and gene 
expression in response to stress 
and hypothyroidism. Altogether, 
these studies place miRNA-medi-
ated regulation in the spotlight dur-
ing heart development and adult 
cardiac physiology.Finally, Zhao et al. (2007) touch on 
a recurrent problem in the miRNA 
field, the difficulty in reliably identify-
ing the targets for any given miRNA. 
Current methods focus on base 
pairing between the miRNA “seed” 
comprising two to seven nucleotides 
and its target mRNA. Despite the 
presence of putative target sites, it 
remains unclear why some target 
mRNAs are strongly repressed but 
other targets with identical sites 
are only weakly repressed. In the 
new work and their previous study 
(Zhao et al., 2007; Zhao et al., 2005), 
the authors introduced an interest-
ing idea for target selectivity that 
depends on the free energy (∆G) 
surrounding the target site. They 
propose that a stable environment 
(low ∆G) might be less accessible to 
the miRNA silencing complex than 
an unstable (high ∆G) environment. 
Analysis of target mRNAs whose 
levels were altered in the absence 
of miR1-2 supports this hypoth-
esis (Zhao et al., 2007). However, a 
genome-wide statistical analysis of 
the average free energy flanking arti-
ficial (shuffled) miRNA target sites 
is needed, together with a rigorous 
assessment of the efficiency of a tar-
get site in the context of a 3′UTR in 
which the ∆G of the 5′ and 3′ flanking 
regions are systematically changed. 
These experiments, together with 
experimental validation of more pre-
dicted targets, will refine current pre-
diction methods and will consolidate 
the energetic considerations guiding 
miRNA-target mRNA interactions.
The Zhao et al. (2007) findings 
have several important implications. 
First, their work identifies miR-1-2 as 
a key miRNA during embryonic and 
adult cardiac function. Second, it 
defines a set of potential miR-1 tar-
get genes whose regulation is likely 
to play crucial roles during cardiac 
development and physiology. Third, 
it supports the hypothesis that high 
free energy flanking the miRNA 
complementary site could be used Cell 129to identify functional targets of miR-
NAs. Finally, given that miR-1-1—
which targets the same sequences 
as miR-1-2—is still expressed in 
miR-1-2-deficient hearts, the study 
by Zhao et al. (2007) indicates that 
miR-1 dosage is important during 
heart development. Therefore, it is 
tantalizing to speculate that envi-
ronmental or genetic conditions that 
affect miR-1 expression levels dur-
ing human embryonic heart devel-
opment could constitute potential 
risk factors for cardiovascular dis-
ease and heart failure in the adult.
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